These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37657281)

  • 1. Clinical characterization and differentiation of B-SNIP psychosis Biotypes: Algorithmic Diagnostics for Efficient Prescription of Treatments (ADEPT)-1.
    Clementz BA; Chattopadhyay I; Trotti RL; Parker DA; Gershon ES; Hill SK; Ivleva EI; Keedy SK; Keshavan MS; McDowell JE; Pearlson GD; Tamminga CA; Gibbons RD
    Schizophr Res; 2023 Oct; 260():143-151. PubMed ID: 37657281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic neural activity differences in psychosis biotypes: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) consortium.
    Thomas O; Parker D; Trotti R; McDowell J; Gershon E; Sweeney J; Keshavan MS; Keedy SK; Ivleva E; Tamminga CA; Pearlson GD; Clementz BA
    Biomark Neuropsychiatry; 2019 Dec; 1():. PubMed ID: 36643612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosis Biotypes: Replication and Validation from the B-SNIP Consortium.
    Clementz BA; Parker DA; Trotti RL; McDowell JE; Keedy SK; Keshavan MS; Pearlson GD; Gershon ES; Ivleva EI; Huang LY; Hill SK; Sweeney JA; Thomas O; Hudgens-Haney M; Gibbons RD; Tamminga CA
    Schizophr Bull; 2022 Jan; 48(1):56-68. PubMed ID: 34409449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Diagnosis and Biotype Comparison Across the Psychosis Spectrum: Investigating Volume and Shape Amygdala-Hippocampal Differences from the B-SNIP Study.
    Guimond S; Gu F; Shannon H; Kelly S; Mike L; Devenyi GA; Chakravarty MM; Sweeney JA; Pearlson G; Clementz BA; Tamminga C; Keshavan M
    Schizophr Bull; 2021 Oct; 47(6):1706-1717. PubMed ID: 34254147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing functional regional homogeneity (ReHo) as a B-SNIP psychosis biomarker using traditional and machine learning approaches.
    Ji L; Meda SA; Tamminga CA; Clementz BA; Keshavan MS; Sweeney JA; Gershon ES; Pearlson GD
    Schizophr Res; 2020 Jan; 215():430-438. PubMed ID: 31439419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating Biomarker Features and Familial Characteristics of B-SNIP Psychosis Biotypes.
    Parker D; Trotti R; McDowell J; Keedy S; Keshavan M; Pearlson G; Gershon E; Ivleva E; Huang LY; Sauer K; Hill S; Sweeny J; Tamminga C; Clementz B
    Res Sq; 2024 Jan; ():. PubMed ID: 38260530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emotional scene processing in biotypes of psychosis.
    Trotti RL; Parker DA; Sabatinelli D; Keshavan MS; Keedy SK; Gershon ES; Pearlson GD; Hill SK; Tamminga CA; McDowell JE; Clementz BA
    Psychiatry Res; 2023 Jun; 324():115227. PubMed ID: 37121219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supervised machine learning classification of psychosis biotypes based on brain structure: findings from the Bipolar-Schizophrenia network for intermediate phenotypes (B-SNIP).
    Koen JD; Lewis L; Rugg MD; Clementz BA; Keshavan MS; Pearlson GD; Sweeney JA; Tamminga CA; Ivleva EI
    Sci Rep; 2023 Aug; 13(1):12980. PubMed ID: 37563219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prodromal period of psychosis: diagnostic criteria.
    Venger O; Bilous V; Striepetova O; Kulivets O; Oliynyk O
    Wiad Lek; 2024; 77(1):47-54. PubMed ID: 38431807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing Psychosis Phenotypes From Bipolar-Schizophrenia Network for Intermediate Phenotypes for Clinical Application: Biotype Characteristics and Targets.
    Clementz BA; Trotti RL; Pearlson GD; Keshavan MS; Gershon ES; Keedy SK; Ivleva EI; McDowell JE; Tamminga CA
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2020 Aug; 5(8):808-818. PubMed ID: 32600898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.
    McKetin R; Baker AL; Dawe S; Voce A; Lubman DI
    Psychiatry Res; 2017 May; 251():349-354. PubMed ID: 28282630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP).
    Tamminga CA; Ivleva EI; Keshavan MS; Pearlson GD; Clementz BA; Witte B; Morris DW; Bishop J; Thaker GK; Sweeney JA
    Am J Psychiatry; 2013 Nov; 170(11):1263-74. PubMed ID: 23846857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of prolonged acoustic startle latency to diagnosis and biotype in the bipolar-schizophrenia network on intermediate phenotypes (B-SNIP) cohort.
    Massa N; Owens AV; Harmon W; Bhattacharya A; Ivleva EI; Keedy S; Sweeney JA; Pearlson GD; Keshavan MS; Tamminga CA; Clementz BA; Duncan E
    Schizophr Res; 2020 Feb; 216():357-366. PubMed ID: 31796306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Working memory predicts presence of auditory verbal hallucinations in schizophrenia and bipolar disorder with psychosis.
    Jenkins LM; Bodapati AS; Sharma RP; Rosen C
    J Clin Exp Neuropsychol; 2018 Feb; 40(1):84-94. PubMed ID: 28562181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of boundaries between mood and psychosis disorder using dynamic functional network connectivity (dFNC) via deep learning classification.
    Rokham H; Falakshahi H; Fu Z; Pearlson G; Calhoun VD
    Hum Brain Mapp; 2023 Jun; 44(8):3180-3195. PubMed ID: 36919656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic efficiency of the CBCL thought problems and DSM-oriented psychotic symptoms scales for pediatric psychotic symptoms.
    Salcedo S; Rizvi SH; Freeman LK; Youngstrom JK; Findling RL; Youngstrom EA
    Eur Child Adolesc Psychiatry; 2018 Nov; 27(11):1491-1498. PubMed ID: 29556765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced task-evoked pupillary response in preparation for an executive cognitive control response among individuals across the psychosis spectrum.
    Karpouzian-Rogers T; Sweeney JA; Rubin LH; McDowell J; Clementz BA; Gershon E; Keshavan MS; Pearlson GD; Tamminga CA; Reilly JL
    Schizophr Res; 2022 Oct; 248():79-88. PubMed ID: 35963057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity of thought disorder predicts psychosis in persons at clinical high-risk.
    Perkins DO; Jeffries CD; Cornblatt BA; Woods SW; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Heinssen R; Mathalon DH; Seidman LJ; Tsuang MT; Walker EF; McGlashan TH
    Schizophr Res; 2015 Dec; 169(1-3):169-177. PubMed ID: 26441004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive and negative symptoms in the psychoses: multidimensional scaling of SAPS and SANS items.
    Minas IH; Stuart GW; Klimidis S; Jackson HJ; Singh BS; Copolov DL
    Schizophr Res; 1992 Dec; 8(2):143-56. PubMed ID: 1457393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A symptom-based continuum of psychosis explains cognitive and real-world functional deficits better than traditional diagnoses.
    Hanlon FM; Yeo RA; Shaff NA; Wertz CJ; Dodd AB; Bustillo JR; Stromberg SF; Lin DS; Abrams S; Liu J; Mayer AR
    Schizophr Res; 2019 Jun; 208():344-352. PubMed ID: 30711315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.